Speakers

Sort by
Newest
Trending
1-30 of 54
Filter
Tristan Searra
Owner at 11:11 CBD LTD
brand, cannabidiol, cannabinoid, cannabis, conor mcgregor, disinfectant, drug test, elon musk, endocannabinoid system, floyd mayweather jr., food, golf, hangover, hemp, medication, organic certification, organic food, plant, retail, smoking, tetrahydrocannabinol, truck driver, united kingdom, vegetable, water
Becky Lynn
Founder & CEO at Evora Women's Health
attention, blinded experiment, breastfeeding, cannabinoid, cannabis, cannabis (drug), chronic pain, clinicaltrials.gov, coffee, coffee bean, coronavirus disease 2019, diesel fuel, distillation, endocannabinoid system, endometriosis, endometrium, estrogen, fallopian tube, follicle-stimulating hormone, follicular phase, food and drug administration, gonadotropin-releasing hormone, hospital, ibuprofen, implantation (human embryo), in vitro, innovation, laboratory, lordosis behavior, luteal phase, luteinizing hormone, menstrual cycle, miscarriage, molecule, ovarian follicle, ovary, ovulation, pain, pharmaceutical industry, pharmacokinetics, pre-eclampsia, progesterone, randomized controlled trial, steam distillation, supercritical fluid, tetrahydrocannabinol, uterus, women's health
Jokūbas Žiburkus
CEO and Co-Founder at Adendox
allosteric modulator, allosteric regulation, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis indica, cytokine, endocannabinoid system, glutamate (neurotransmitter), hashish, hippocampus, inflammation, medical cannabis, nervous system, neuron, neuroprotection, neuroscience, receptor antagonist, synapse, tetrahydrocannabinol, tetrahydrocannabinolic acid
Israel Garcia
Director Of Chemistry at Bayou City Hemp Company
bioavailability, brand, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, emulsion, endocannabinoid system, food and drug administration, health, human, ibuprofen, memory, omega-3 fatty acid, omega-6 fatty acid, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, rapid eye movement sleep, route of administration, shelf life, sleep, solution, tablet (pharmacy), tetrahydrocannabinol, transparency and translucency
Chip Paul
President & Co-Founder at GnuPharma
alternative medicine, alzheimer's disease, antidepressant, antipsychotic, appetite, autism, autoimmune disease, belief, bioavailability, bipolar disorder, brand, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, cannabis strain, cattle feeding, certificate of analysis, chemotherapy, consumer protection, depression (mood), dietary supplement, docosahexaenoic acid, dopamine, dose (biochemistry), dronabinol, drug development, eating, eicosapentaenoic acid, emergency medical technician, emulsion, endocannabinoid system, endocrinology, epilepsy, fat, fibromyalgia, fish oil, food and drug administration, gpr55, health care, hormone, hunger (physiology), hypertension, hypothalamus, irritable bowel syndrome, major depressive disorder, management of depression, mdma, medical cannabis, medicine, mental health, mood stabilizer, nonverbal communication, norepinephrine, obesity, omega-3 fatty acid, omega-6 fatty acid, paracetamol, parkinson's disease, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, pharmacy, placebo, post-traumatic stress disorder, prescription drug, probiotic, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, selective serotonin reuptake inhibitor, serotonin, shelf life, sleep, substance dependence, synthetic cannabinoids, tablet (pharmacy), tetrahydrocannabinol, topical medication, traditional chinese medicine, treatment-resistant depression, triglyceride, trpv1, vitamin c, well-being
Priscilla Agoncillo
Co-Founder at Original Breeders League
anti-inflammatory, antidepressant, anxiolytic, autism, belief, brand, cancer, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis industry, democratic party (united states), dispensary, dose (biochemistry), dravet syndrome, dronabinol, education, emergency medical technician, endocannabinoid system, entourage effect, epilepsy, food and drug administration, free market, gerrymandering, good manufacturing practice, hair loss, health care, major depressive disorder, management of depression, mdma, mechanism of action, medical cannabis, medication, medicine, mental disorder, mental health, mood stabilizer, neuroplasticity, neurotransmitter, paramedic, pediatrics, pharmaceutical industry, pharmacology, pharmacy, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychiatry, psychoactive drug, psychology, schizophrenia, selective serotonin reuptake inhibitor, sense, serotonin, substance dependence, swing state, syndrome, tetrahydrocannabinol, tony montana, treatment-resistant depression
Graciela Moreno
Director of Member Engagement at CBD Industry Association
alternative medicine, anti-inflammatory, appetite, audit, board certification, bong, brand, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, central processing unit, chemotherapy, convertible bond, cosmetics, crowdfunding, debenture, debt, dietary supplement, discounting, dispensary, dose (biochemistry), dravet syndrome, education, emergency medical technician, endocannabinoid system, endocrinology, epilepsy, fda food safety modernization act, financial capital, food, food and drug administration, food safety, free market, good manufacturing practice, hair loss, health claim, hormone, interest, interest rate, investment, investor, iso 9000, kentucky, medical cannabis, medical school, medication, medicine, mental disorder, mental health, mergers and acquisitions, mind, nsf international, nursing, obesity, ondansetron, opiate, option (finance), organic certification, over-the-counter drug, paramedic, pathology, pediatrics, physician, prescription drug, probiotic, psychopharmacology, quality management system, regulatory compliance, research, retail, safety, schizophrenia, selective serotonin reuptake inhibitor, sleep, social stigma, specialty (medicine), stock, stock dilution, substance abuse, syndrome, synthetic cannabinoids, tetrahydrocannabinol, therapy, tony montana, traditional chinese medicine, valuation (finance), verification and validation, vitamin c, well-being
Michael Chang
Medical Director at Nutex Health
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Jeff Konin
Clinical Professor at College of Nursing & Health Sciences at Florida International University
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Joseph Rosado
Physician and Medical Director at International Medical Consultants and Cannabidiol Life
adalimumab, alzheimer's disease, analgesic, anticoagulant, antipsychotic, arthritis, autoimmune disease, benzodiazepine, bioavailability, bipolar disorder, bleeding, brand, budtender, cancer, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, cannabis strain, certificate of analysis, depression (mood), dispensary, dopamine, dose (biochemistry), dravet syndrome, drug overdose, edema, education, effects of cannabis, emergency department, emergency medical technician, endocannabinoid system, epilepsy, fibromyalgia, food and drug administration, free market, good manufacturing practice, gpr55, hair loss, hiv, homeostasis, hydroxychloroquine, hypertension, indication (medicine), insomnia, irritable bowel syndrome, lupus, medical cannabis, medical prescription, medical school, medicine, mental disorder, mental health, methotrexate, morphine, norepinephrine, omega-6 fatty acid, opiate, opioid, oxycodone, oxycodone/paracetamol, pain management, paracetamol, paramedic, parkinson's disease, pediatrics, peripheral neuropathy, pharmaceutical industry, pharmacology, physician, placebo, placebo-controlled study, post-traumatic stress disorder, prescription drug, psilocybin mushroom, psychological trauma, randomized controlled trial, rhabdomyosarcoma, rheumatoid arthritis, schizophrenia, serotonin, spasticities, sports medicine, syndrome, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, tony montana, topical medication, transgenerational trauma, vaporizer (inhalation device), warfarin
David McLaughlin
Founder & CEO at Sati Organics
advertising, aphria (company), brand, cannabidiol, cannabinoid, cannabis, cannabis edible, chocolate, coca-cola, coffee, contract, cosmetics, dietary supplement, distribution (marketing), endocannabinoid system, flavor, food, food and drug administration, food science, hot chocolate, kool-aid, liquid, marketplace, minimum viable product, money, mountain dew, nestea, novel food, pay to play, pepsi, pharmacy, pricing, recycling, retail, search engine optimization, shelf life, soft drink, tea, tetrahydrocannabinol, toast (honor), whole foods market, yeast
Joel Dar
Founder & CEO at Gataka Wellness
advertising, aphria (company), brand, cannabidiol, cannabinoid, cannabis, cannabis edible, chocolate, coca-cola, coffee, contract, cosmetics, dietary supplement, distribution (marketing), endocannabinoid system, flavor, food, food and drug administration, food science, hot chocolate, kool-aid, liquid, marketplace, minimum viable product, money, mountain dew, nestea, novel food, pay to play, pepsi, pharmacy, pricing, recycling, retail, search engine optimization, shelf life, soft drink, tea, tetrahydrocannabinol, toast (honor), whole foods market, yeast
Kevin Carrillo
Chief Operating Officer at Cannabinoid Nation
advertising, arthritis, audience measurement, blog, brand, brand awareness, budtender, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis edible, chocolate, coca-cola, contract, dietary supplement, digital marketing, effects of cannabis, emergency department, endocannabinoid system, facebook, fibromyalgia, food, food science, game balance, google, google search, gpr55, hashtag, homeostasis, hot chocolate, hydroxychloroquine, instagram, internet, linkedin, liquid, medical school, medicine, minimum viable product, money, morphine, news, newspaper, opiate, pay to play, pepsi, placebo, product sample, psilocybin mushroom, randomized controlled trial, research, search engine optimization, shelf life, small business, social media, social media marketing, sports medicine, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, twitter, vaporizer (inhalation device), whole foods market, yeast, youtube
Kerry Brown
XO at Factory6
advertising, brand, cannabidiol, cannabinoid, cannabis, cannabis edible, chocolate, coca-cola, contract, dietary supplement, endocannabinoid system, food, food science, hot chocolate, liquid, minimum viable product, money, pay to play, pepsi, search engine optimization, shelf life, tetrahydrocannabinol, whole foods market, yeast
Elyse Gordon
Director of Food and Comic Relief at From Soil to Soul
advertising, amazon (company), audit, brand, brand loyalty, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis edible, chocolate, coca-cola, communication protocol, contract, dietary supplement, due diligence, endocannabinoid system, food, food and drug administration, food science, globalization, gluten-free diet, good manufacturing practice, hemp, hot chocolate, insurance, liquid, margin of error, minimum viable product, money, nsf international, organic certification, pay to play, pepsi, reason, regulatory compliance, risk management, sales, search engine optimization, shelf life, software , target corporation, tetrahydrocannabinol, walmart, whole foods market, yeast
Mike Sandoval
President at Sante Laboratories
accuracy and precision, analytical chemistry, aspergillosis, bank, bioavailability, brand, breakfast, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemical substance, chemistry, competition, consumer protection, conversation, crystallization, cytochrome p450, diclofenac, dietary supplement, distillation, dose (biochemistry), dream, drug development, due diligence, electronic cigarette, emulsion, endocannabinoid system, experiment, expert, expungement, food and drug administration, frosted mini-wheats, health, human, humidity, ibuprofen, immunodeficiency, infection, information, insurance, investor, laboratory, loan, market (economics), medical cannabis, memory, mold, money, mycotoxin, occupational safety and health, omega-3 fatty acid, omega-6 fatty acid, paracetamol, petroleum, ph meter, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, rapid eye movement sleep, reason, regulatory compliance, route of administration, safety, scientific method, sesame, shelf life, sleep, solution, stove, tablet (pharmacy), technology, temperature, tetrahydrocannabinol, the matrix, traceability, tractor, transparency and translucency, treaty, understanding
Dr. Zeid Mohamedali, MD, PhD, FRCS(C)
Chief Medical Officer at Zenabis
addiction, anxiety, cancer, cannabidiol, cannabis culture, cannabis culture?, endocannabinoid system, gloss phobia, hydromorphone, medical prescription, pain, perception
Jeffrey Raber
CEO at The Werc Shop
biochemistry, cannabidiol, cannabinoid, cannabis, cannabis indica, cannabis sativa, cannabis strain, dose (biochemistry), electronic cigarette, emulsion, endocannabinoid system, enzyme, food and drug administration, hash oil, hydroponics, medical cannabis, nature, organic chemistry, psychoactive drug, reaction rate, terpene, tetrahydrocannabinol, toxicity, vitamin e, volatile organic compound
Jimmy Castillo
Chief Innovation Officer at Jenny's Rose
cancer, cannabidiol, cannabinoid, cannabis, chemotherapy, dietary supplement, dose (biochemistry), dose (biochemistry)?, doses (biochemistry), endocannabinoid system, entourage effect, fat, ginger, medication, medicinal plants, opiate, opioid, pain management, pharmacy, physician, prescription drug, rheumatology, rose, systemic lupus erythematosus, tetrahydrocannabinol, turmeric, vitamin c
Jessie Kempf
Co-Founder at Mend
cancer, cannabidiol, cannabinoid, cannabis, chemotherapy, dietary supplement, dose (biochemistry), dose (biochemistry)?, doses (biochemistry), endocannabinoid system, entourage effect, fat, ginger, medication, medicinal plants, opiate, opioid, pain management, pharmacy, physician, prescription drug, rheumatology, rose, systemic lupus erythematosus, tetrahydrocannabinol, turmeric, vitamin c
Nicole Davidsohn
Co-Founder & Formulator at Eva
agriculture, attention, ayurveda, cancer, cannabidiol, cannabinoid, cannabis, chemotherapy, china, chinese herbology, dietary supplement, dose (biochemistry), dose (biochemistry)?, doses (biochemistry), drug, endocannabinoid system, entourage effect, fat, flower, food, food and drug administration, ginger, grocery store, heat, hemp, medication, medicinal plants, news, nutraceutical, opiate, opioid, pain management, percentage, pesticide, pharmaceutical industry, pharmacy, physician, prescription drug, retail, rheumatology, rose, runway, seed, systemic lupus erythematosus, tetrahydrocannabinol, traditional chinese medicine, turmeric, united states department of agriculture, vitamin c
Guy Rocourt
Co-Founder & Chief Product Officer at Papa and Barkley
1996 california proposition 215, agriculture, analytics, antioxidant, apple, biochar, biodiesel, brand, brewery, business model, butter, calibration, cancer, candy, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis sativa, certificate of analysis, chemical engineering, chemist, chemotherapy, chromatography, classified information, clinical trial, coconut oil, colorado, compliance training, critical mass, cultivar, dietary supplement, dominance (genetics), dose (biochemistry), dose (biochemistry)?, doses (biochemistry), electrical equipment in hazardous areas, electronic cigarette, endocannabinoid system, engineering, entourage effect, ethanol, farm, farmer, fat, fda warning letter, feeling, flower, food, food and drug administration, freeze-drying, generally recognized as safe, ginger, good manufacturing practice, gummy candy, hash oil, hashish, hemp, herb, high-performance liquid chromatography, ice, impatiens necrotic spot virus, infection, intrinsic safety, inventory, irrigation in viticulture, juice, laboratory, laboratory., lavandula, liquid, market (economics), marketplace, median lethal dose, medication, medicinal plants, mining, monopoly, natural selection, nuclear magnetic resonance spectroscopy, nutraceutical, occupational safety and health, occupational safety and health administration, oil refinery, olive, olive oil, ontario, opiate, opioid, orange juice, organic compound, over-the-counter drug, packaging, and labeling, pain management, pathogen, pepsi, personal protective equipment, pharmaceutical industry, pharmacovigilance, pharmacy, phase (matter), phenotype, physician, phytochemical, piano, plant, plant breeding, plant nursery, plant tissue culture, plant virus, plumbing, prescription drug, pressure vessel, quality management system, rancidification, reason, regulatory compliance, rheumatology, root, rose, rosin, scott gottlieb, sedative, shelf life, shore durometer, south carolina, soybean, steel, steel-toe boot, supermarket, systemic lupus erythematosus, tax, technology, terpene, terroir, tetrahydrocannabinol, theory, tree, trichome, turmeric, united states farm bill, vegetative reproduction, vermont, virus, vitamin c, vitamin e, vitis, volatile organic compound, warehouse, washing machine, water, wheat, whole foods market, xfinity
Daniel Sliva
CSO & Founder at DSTest Laboratories
allosteric regulation, anti-inflammatory, antiviral drug, aspirin, assay, attention, bioavailability, biology, blinded experiment, book, bootleg recording, brand, brand loyalty, breast cancer, cancer, cannabidiol, cannabidiol is, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cardiovascular disease, cell signaling, chemical substance, chemistry, chromatography, chronic pain, cigarette, clinical trial, clinicaltrials.gov, coffee, coffee bean, common sense, coronavirus disease 2019, crisis management, diesel fuel, dietary supplement, direct-to-consumer advertising, distillation, dose (biochemistry), drug, drug test, end-user, endocannabinoid system, experiment, first, pass effect, flax, food, food and drug administration, fraud, gastrointestinal tract, germination, good manufacturing practice, green tea, hemp, hepatotoxicity, high-performance liquid chromatography, hospital, ibuprofen, in vitro, infection, inflammation, innovation, insomnia, intravenous therapy, iso/iec 17025, knowledge, laboratory, ligand (biochemistry), lipid, marketplace, medication, melatonin, micro-encapsulation, mining, molecule, nabiximols, nanoparticle, national institutes of health, nutraceutical, occupational safety and health, omega-3 fatty acid, omega-6 fatty acid, organ transplantation, osteoarthritis, packaging and labeling, pain, paracetamol, peripheral neuropathy, petroleum, pharmaceutical industry, pharmacokinetics, pharmacology, psychoactive drug, randomized controlled trial, reason, receptor (biochemistry), recycling, reliability engineering, research, right to know, risk, route of administration, sense, serotonin, sleep disorder, social supports, steam distillation, steve jobs, supercritical fluid, taste, terpene, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, the end-user, thin-layer chromatography, toxicity, vitamin, warranty, waste, water, women's health
Adam Abodeely
Board Certified Surgeon & CEO-Founder at ReserveMD
adoption, allosteric modulator, alternative medicine, anesthesia, anticoagulant, antihypertensive drug, appetite, audit, background check, bank, benzodiazepine, best practice, bioavailability, bleeding, bloating, blood sugar level, board certification, brand, breathing, budtender, c-reactive protein, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis sativa, carbohydrate, central processing unit, charlotte's web (cannabis), chemotherapy, chemotherapy-induced nausea and vomiting, clinical trial, commerce clause, controlled substances act, craft brewery and microbrewery, crohn's disease, dementia, depression (mood), diarrhea, dietary supplement, disease, dose (biochemistry), drug, drug development, drug overdose, due diligence, edema, emergency department, endocannabinoid system, entourage effect, fda food safety modernization act, fda warning letter, fibromyalgia, flavonoid, food, food and drug administration, food safety, foodborne illness, gastrointestinal disease, gastroparesis, general surgery, good manufacturing practice, gut–brain axis, headache, heartburn, hemp, hemp oil, heroin, homeostasis, ibuprofen, ileostomy, immune system, indication (medicine), inflammation, inflammatory bowel disease, inhaler, intestinal permeability, iso 9000, lemon, lobbying, lung volumes, macrophage, medical cannabis, medical prescription, medication, mind, morphine, nanotechnology, nausea, neurology, neuron, neurosurgery, neurotransmitter, nicotine, nsf international, nutraceutical, opiate, opioid, opioid epidemic in the united states, opioid overdose, over-the-counter drug, oxycodone, oxycodone/paracetamol, pain, pain management, pathology, patient, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacokinetics, pharmacology, pharmacy, physician, placebo, placebo-controlled study, polypharmacy, prescription drug, psychoactive drug, quality management system, reason, regulatory compliance, rhabdomyosarcoma, risk, route of administration, safety, scientific method, sensitivity and specificity, serotonin, serotonin syndrome, signal transduction, spasticities, stress (biology), surgery, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, tetrahydrocannabinol acid, therapeutic index, therapy, toxicity, ulcerative colitis, understanding, verification and validation, warfarin, water
Allen Manison
Chief Science Officer at Noetic Nutraceuticals, LLC
adipose tissue, antidepressant, aromatherapy, arthritis, bank, brain damage, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), chronic condition, chronic pain, clinical trial, crop insurance, curriculum, dose (biochemistry), endocannabinoid system, evidence-based medicine, fibromyalgia, finance, food and drug administration, immune system, inflammation, lymphocyte, major depressive disorder, medical cannabis, medical prescription, medication, organized crime, pain disorder, pain management, payment, pharmaceutical industry, placebo-controlled study, prescription drug, psychotherapy, tetrahydrocannabinol, tetrahydrocannabinol acid
Randy Fink
Physician, Medical Director at Miami Center of Excellence, LLC
alternative medicine, anesthesia, antihypertensive drug, anxiety, arm, aromatherapy, bank, bioidentical hormone replacement therapy, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis indica, cannabis sativa, clinical trial, crohn's disease, crop insurance, curriculum, depression (mood), diarrhea, dose (biochemistry), endocannabinoid system, entourage effect, erection, evidence-based medicine, finance, food and drug administration, gastrointestinal disease, general surgery, gums, hemp, human sexual activity, ileostomy, inflammatory bowel disease, libido, medical cannabis, medical prescription, medication, mind, organized crime, orgasm, pain management, payment, pharmaceutical industry, pharmacology, pharmacy, placebo-controlled study, prescription drug, psychoactive drug, retail, route of administration, tadalafil, terminal illness, tetrahydrocannabinol, therapeutic index, transgender hormone therapy (male-to-female), ulcerative colitis
Sean Colvin
Senior Scientist at TreeHouse Biotech
alternative medicine, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis (drug), crohn's disease, drink, endocannabinoid system, entourage effect, gpr55, hash oil, immune system, immunodeficiency, liquor, moonshine, neuron, pharmaceutical industry, pharmacology, prohibition, receptor (biochemistry), tetrahydrocannabinol, weight training
Tyrell Towle
Director of Chemistry at MedPharm Holdings
alternative medicine, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis (drug), crohn's disease, drink, endocannabinoid system, entourage effect, gpr55, hash oil, immune system, immunodeficiency, liquor, moonshine, neuron, pharmaceutical industry, pharmacology, prohibition, receptor (biochemistry), tetrahydrocannabinol, weight training
Julie P. Fry
Cannabis Industry Consultant
alternative medicine, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis (drug), crohn's disease, drink, endocannabinoid system, entourage effect, gpr55, hash oil, immune system, immunodeficiency, liquor, moonshine, neuron, pharmaceutical industry, pharmacology, prohibition, receptor (biochemistry), tetrahydrocannabinol, weight training
Joshua Jones
Founder at Jonesing Labs
alternative medicine, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis (drug), crohn's disease, drink, endocannabinoid system, entourage effect, gpr55, hash oil, immune system, immunodeficiency, liquor, moonshine, neuron, pharmaceutical industry, pharmacology, prohibition, receptor (biochemistry), tetrahydrocannabinol, weight training
1 2